Role of imaging in the evaluation of axillary nodes and metastatic disease from breaszt carcinoma;Imagerie dans le bilan d'extension ganglionnaire et métastatique du cancer du sein

Journal de Radiologie

Volumn 86, Issue 11, 2005, Pages 1649-1657

  Balu Maestro, C ^a   Chapellier, C ^a   Carrier, P ^a   Darcourt, J ^a   Ettore, F ^a   Raoust, I ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Breast cancer; Disease staging; Imaging

Indexed keywords

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; CLINICAL EXAMINATION; COST BENEFIT ANALYSIS; EVALUATION; HUMAN; LYMPH NODE METASTASIS; REVIEW; RISK FACTOR;

EID: 27944455235     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0221-0363(05)81506-9     Document Type: Review

References (48)

1. ANAES. Suivi des patientes traitées pour un cancer du sein non métastasé. Recommandations pour la Pratique Clinique. ANAES 1998.
2. ème édition) édition John Libbey Eurotext, France 2001;48-90.
3. Bruneton JN, Caramella E, Héry M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 1986;158:325-6.
4. Walsh JS, Dixon JM, Chetty U, Paterson D. Coulour Doppler studies of axillary node metastases in breast cancer carcinoma. Clin Radiol 1994;49;189-91.
5. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2354-60.
6. Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
7. Singletary SE, Allred C, Ashley P et al. Revision of the American joint committee on cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-36.
8. Viale G, Maiorano E, Mazzarol G et al. Histologic dissection and clinical implications of micrometastasis in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-84.
9. Bellocq JP, Marin C, Chenard MP. Curage axillaire et ganglion sentinelle: jusqu'où étendre l'analyse histologique? Bulletin de la Division Française de l'AIP 2000;32:38-41.
10. Guinebretière JM, Contesso G. "Micro-métastase": Le point de vue du pathologiste. Bull Cancer 2001;88:549-60.
11. Cote RJ, Peterson HF, Chaiwun B et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999;354:896-900.
12. Discussion Lancet 2001;358:1814-6.
13. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL, Shenk RR. Axillary lymph node metastases: Screening with [F-18] 2-deoxy-2 fluoro-D-glucose (FDG) PET. Radiology 1997;203:323-7.
14. Crippa F, Agresti R, Seregni E et al. Prospective evaluation of Fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
15. Hubner KF, Smith GT, Thie JA, Bell JL, Nelson HS, Hanna WT. The potential of F-18-FDG PET in breast cancer. Detection of primary lesions, axillary lymph node metastases, or distant metastases. Clin Positron Imaging 2000;3:197-200.
16. Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axillar related to surgery and immunocytochemistry. Eur J Nucl Med 1996;23:1588-93.
17. Rigo P, Mourou M.Y. Apport de la TEP au 18-FDG dans le diagnostic, dans le bilan d'extension et la prise en charge du cancer du sein. J. Le Sein 2002;12:97-101.
18. Frija J, Bourrier P, Zagdanski AM, De Kerviler E. Le diagnostic d'un ganglion tumoral. J Radiol 2005;86:113-25.
19. Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2002;10:1464-71.
20. Suzuma T, Yoshimura G, Umemura T, Tamaki T, Yang QF, Oura S. MR-axillography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection. Breast Cancer 2002;9:69-74.
21. Taupitz M, Wallis F, Heywang-Koebrunner SH et al. Axillary lymph node MR imaging with Sinerem (R) in patients with suspected breast cancer. Radiology 2000;Abst 1172:369.
22. Michel A, Sven C, Thomas M. Preoperative Breast Cancer staging: MR Imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 2002;225:527-36.
23. De Kanter AY, Van Eijck CHJ, Van Geel AN et al. Mutlicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 1999;86:1459-62.
24. Feu J, Tresserra F, Fabregas R et al. Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection. Radiology 1997;205:831-5.
25. Verbanck J, Vandewiele I, De Winter H, Tytgat J, Van Aelst F, Tanghe W. Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: a prospective study in 144 consecutive patients. J Clin Ultrasound 1997;25:53-6.
26. Bonnema J, Van Geel AN, Van Ojen B et al. Ultrasound-guided aspiration biopsy for detection of non palpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 1997;21:270-4.
27. Tateishi T, Machi J, Feleppa EJ et al. In B-mode ultrasonographic criteria for diagnosing axillary lymph node metastasis of breast cancer. J Ultrasound Med 1999;18:349-56.
28. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar A, Hortobagyi GN. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997;3:1565-9.
29. Solbiati L, Rizzato G, Charboneau JW. High frequencies, Doppler and interventional procedures. In "Ultrasound of superficial structures". Churchil Livingstone eds, New York 1995;279-301.
30. Vassalo P, Wernecke K, Roos N, Peters PE. Differentiation of bening from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992;183:215-20.
31. Yang WT, Chang J, Metreweli C. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 2000;215:568-73.
32. Steinkamp HG, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R. Cervical lymphadenopathy: ratio of long-to short-axis diameter as a predictor of malignancy. Br J Radiol 1995;68:266-70.
33. Evans RM, Ahuja A, Metreweli C. The linear echogenic hilus in cervical lymphadenopathy - a sign of benignity or malignancy? Clin Radiol 1993;47:262-4.
34. Rubaltelli L, Proto E, Salmaso R, Bortoletto P, Candiani F, Cagol P. Sonography of abnormal lymph nodes in vitro: correlation of sonographic and histologic findings. AJR 1990;155:1241-4.
35. Bleuse A, Balu-Maestro C, Chapellier C, Marcy PY, Bruneton JN. T1 breast cancer in patients over 70 years. Interest and limits of axillary ultrasound. J Ultrasound Med 1999;18:S164.
36. Lam WWM, Yang WT, Chan YL, Stewart IET, Metreweli C, King W. Detection of axillary lymph node metastases in breast carcinoma by Technetium 99m Sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 19961;23:498-503.
37. Bleuse A, Maestro C, Chapellier C, Chauvel C. Confrontation entre échographie des aires ganglionnaires et résultats anatomopathologiques du curage axillaire. Communication aux JFR' 2002, Paris 19-23.10. 2002, J Radiol 2002;83:S13.
38. Vaidya JS, Vyas JJ, Thakur MH, Khandelwal KC, Mittra I. Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 1996;22:140-3.
39. Jaffer S, Zakowski M. Fine-needle aspiration biopsy of axillary lymph nodes. Diagn Cytopathol. 2002;26:69-74.
40. Oruwari JU, Chung MA, Koelliker S, Steinhoff MM, Cady B. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Am J Surg. 2002;184:307-9.
41. Balu-Maestro C, Chapellier C, Chauvel C, et al. Echographie ganglionnaire axillaire. J. Le Sein. 2000;10:230-6.
42. Krishnamurthy S, Sneige N, Bedi DG et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002;95:982-8.
43. Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, Obdeijn IM, Urich D, Van Der Kwast TH. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer. 2003;39:170-4.
44. Damera A, Evans AJ, Cornford EJ et al. Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer. 2003;89:1310-3.
45. Morton MJ, Charboneau JW, Banks PM. Inguinal lymphadenopathy simulating a false aneurysm in color flow Doppler sonography. AJR 1988;151:1555.
46. Tschammler A, Ott G, Schang T, Seelbach-Goebel B, Schwager K, Hahn D. Lymphadenopathy: differentiation of benign from malignant disease-color Doppler US assessment of intranodal angioarchitecture. Radiology 1988;208:117-23.
47. Moritz JD, Ludwig A, Oestmann JW. Contrast-enhanced color Doppler sonography for evaluation of enlarged cervical lymph nodes in head and neck tumors. AJR 2000;174:1279-84.
48. Mattrey RF, Kono Y, Baker K, Peterson T. Sentinel lymph node imaging with microbubble ultrasound contrast material. Acad Radiol 2002;1:S231-5.